Porvair’s membrane filters ensure higher flow rates
Designed to withstand pressure during filtration
The rigorous construction of these pleated membrane cartridges ensures higher flow rates, lower pressure differentials and faster process times, the company says. Independently verified to meet USP Class VI and ISO 10993, each filter is provided with a certificate of quality. Manufacturing takes place in an ISO Class 5 cleanroom in accordance with accredited quality procedures and the membrane is protected from damage during production by the inner and outer drainage layers that maintain the pleat pack structure.
The filter's inner core comprises a thermoplastic material that further supports the pleat pack and draws the filtrate through its perforations to the outlet of the cartridge. Snugly encased in a polymeric outer cage and securely fitted with sanitary design adaptors that provide optimal sealing and safety against bypass, each cartridge is identified by a serial number embossed on the outer sleeve, providing full traceability to all FDA CFR 21 and EC-approved manufacturing components.
The supply chain is closely monitored with in-house production of the filter’s outer cage, core and end cap. Careful attention to package design minimises the chance of damage to the filters during transit and storage, says Porvair.
Assurance of the high quality of Porvair membrane cartridge filters is further demonstrated by post-manufacture integrity testing, which is a non-destructive means of determining oversized pores or defects.
The integrity test parameters employed by Porvair are correlated to the filter's microbial retention capabilities as determined during validation in accordance with ASTM F838-05, HIMA and PDA Technical Reports 26 and 40. Any filter that fails integrity testing is immediately discarded.
Porvair Filtration Group is an international leader in the development and supply of materials and products for applications in filtration and separation. It has offices and manufacturing sites in the UK, Europe and the US and a worldwide network of distributors.
You may also like
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
Manufacturing
etherna's mRNA and LNP platforms advance Dropshot Therapeutics' renal disease programme to clinical stage
etherna has announced that partner Dropshot Therapeutics has validated its platforms in preclinical renal disease research and will now progress to IND-enabling studies, with etherna providing GMP manufacturing support ahead of planned Phase I clinical trials in 2027
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
From bespoke to scalable: closing the manufacturing gap in advanced therapeutics
Dr Kevin Robinson (KSR) spoke to Cytiva’s Nicolas Pivet (NP), Vice President of Manufacturing and Digital Solutions, to find out how digitalisation and scalable manufacturing platforms are shaping the next phase of advanced therapeutics
Manufacturing
Piramal Pharma Solutions announces partnership with Botanix to support drug substance development
Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, to support the development and commercial supply of Sofdra. Sofdra is the first and only FDA-approved new chemical entity (NCE) for the treatment of primary axillary hyperhidrosis. Through this partnership, Piramal Pharma Solutions will leverage the strength of its North American drug substance facilities to support robust, consistent patient access to Sofdra
Manufacturing
ProtaGene and Merck partner to deliver end-to-end biologics testing
The duo will combine ProtaGene's early-stage biologics expertise with Merck's BioReliance GMP testing infrastructure, offering biopharmaceutical customers an integrated testing solution across the full drug development lifecycle